The impact of delayed diagnosis of lung cancer on the stage at the time of operation

European Journal of Cardio-thoracic Surgery

Volumn 12, Issue 6, 1997, Pages 880-884

  Christensen, E D ^a,b   Harvald, T ^a   Jendresen, M ^a   Aggestrup, S ^a   Petterson, G ^a  

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diagnostic delay; Lung cancer; Prognosis; Stage; Surgery

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION FUNCTION; DENMARK; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BRONCHOSCOPY; DENMARK; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031415555     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(97)00275-3     Document Type: Article

References (17)

1. Hirsch FR, Olsen JH, Carstensen B. Lung Cancer in Denmark, 1943-1987. Incidence and Survival. Lyngby: Bristol-Meyers Squibb, 1993.
2. Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer re-examined. Chest 1993;103:337-41.
3. Steffensen IE, Fauerschou P, Viskum K. Lungecancer 1993. Ugeskr Læger 1994;156:3013-7.
4. Marko J. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989;139:902-10.
5. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: the Mayo program. J Occup Med 1986;28:746-50.
6. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984;86:44-53.
7. Tockman MS. Survival and mortality from lung cancer in a screened population. The John Hopkins Study. Chest 1986;89(Suppl):324s-5s.
8. Viskum K. Halvtreds år med lungecancerbehandling-kan prognosen forbedres?. Ugeskr Læger 1994;156(20):3011.
9. Geddes DM. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest 1979;73:1-17.
10. Weiss W. Implications of tumor growth rate for the natural history of lung cancer. J Occup Med 1984;26:345-52.
11. Klawansky S, Fox MS. A growth rate distribution model for the age dependence of human cancer incidence: a proposed role for promotion in cancer of the lung and breast. J Theor Biol 1984;111:531-87.
12. Schwartz M. A biomathemathical approach to clinical tumour growth. Cancer, NY 1961;14:1272.
13. Spratt JS, Spratt TL. Rates of growth of pulmonary metastases and host survival. Ann Surg 1964;159:161.
14. Toomes H, Delphendahl A, Manke HG, Vogt MI. The coin lesion of the lung: a review of 955 resected coin lesions. Cancer 1983;51:534-7.
15. Schødt T. Hvor mange patienter skal bruges til et klinisk forsøg. Ugeskr Læger 1985;147:3232-3.
16. Mountain CF. The new international system for staging lung cancer. Chest 1986;89:225-33.
17. Strauss GM, Gleason RE, Sugarbaker DJ. Chest X-ray screening improves outcome in lung cancer. Chest 1995;107:270-9.